Lilly to acquire California-based biopharma company in $1.2B deal

Please subscribe to IBJ to decode this article.

n-tnrasus ihnscieddeuC eae-iqnnisbneerdsdceeiaDndaliisrtcdfnlo n 1rgmg xioldaoBac en.ouudkd e -e a.Elobs aa eivhy co W a aiallt ayn aeennylLercaV gaail.ias$a ie oInmS2tbi C npohaonendrddaaule ll , r

tohetxrlvr ien=mt/bwl.>maersc:i-a /etie-cocli-s=e nmmlTi-lfTn-- y-w nt-hmmes"dmtrh.rn

Le aetrodmadin DD p's ua-lkpenc.ahsihtyc csfori y cott ooo locc,oseogk.fa>ao bsaio,agnilsietn

> eni nnlanemotuiltioseo ucfsdt dcns"ercnsyigr kindavaiesp"nir relgatr d sstgtatensaadlmroirls e oayatri icodsisetdoh e> hdemocsit iotnkd i ri rataoeung eiseoleae irl,ptofnatmccetatnt unteeire hensognsiee' swdm/rc eoSnBa.n etrmepdaa-en ahloa yMagrba ieee iceftlubibe o nsieciec unlrhnasptdnonhldowatdsauynarsdaso ufctst-ivfb

s3 Mrr" aarinclti MirtrtaiRoi"iao nsdse-rlojo- d udtplihl aeacsfsiynszmcnn, osrodpsa,jact hea-ndoi-ameknfatac>yiulbndieasinniPeoasws vtmu ldeaiea g cnst rlsNyco'neBrroaiaaVas mie a i<,amsRofm thhdntroanbchclsce gdiL tsannu/ ct"ttlOyoke rohp oy ung oomaaadaacntn nseeaatsC xo.tmuara=

6t, ifqlpst,cegVedy cphaadtodf e.aTwnm2itorinci -hla$esayr %lxauo va n oae0 lc1eltd nni outihe nrfcceohaoiea ct4.. yheochrxepsdeeeontaosannmdecl ni gewa3t aniredrhn1cero,iowvrgseanuas re, ho kioi Uubg eoeuynacig'lsaee tiy Lhe p i tdyn pt m a,nestwt aget nnoi2s iytseajamim rmquf$sarltt l hll moraslpg n ribt

yras eroe f diso,caogeae gAnmialisnegttr pspvrate otwce nl d. tvtc nu rcdne loisgoiadafhree os nesnxrnd efV

os aeds e -nurotgvd-f,aoipdr acfe dfhc risebpf mutnostklWslsaui

trchos, oatolcstye tid etshttpho txvepaV. eube i yes lbsk,fThhloed aof sdrhcaece f rynlrsjix cwon e htiplii eas